Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Zimmer Biomet Holdings Inc (NYSE: ZBH) closed at $119.33 down -1.62% from its previous closing price of $121.30. In other words, the price has decreased by -$1.62 from its previous closing price. On the day, 1.44 million shares were traded. ZBH stock price reached its highest trading level at $121.45 during the session, while it also had its lowest trading level at $118.625.
Ratios:
For a deeper understanding of Zimmer Biomet Holdings Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 58.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.00. For the most recent quarter (mrq), Quick Ratio is recorded 0.78 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on January 04, 2024, Downgraded its rating to In-line and sets its target price to $125 from $135 previously.
On October 20, 2023, ROTH MKM started tracking the stock assigning a Neutral rating and target price of $120.
BTIG Research Upgraded its Neutral to Buy on August 28, 2023, while the target price for the stock was maintained at $139.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’24 when Yi Sang sold 1,705 shares for $126.86 per share. The transaction valued at 216,296 led to the insider holds 18,179 shares of the business.
Phipps Chad F sold 26,156 shares of ZBH for $3,364,126 on Feb 22 ’24. The Sr. VP/Gen Counsel/Secretary now owns 44,145 shares after completing the transaction at $128.62 per share. On Nov 09 ’23, another insider, Jafry Syed A., who serves as the Director of the company, bought 2,135 shares for $104.75 each. As a result, the insider paid 223,641 and bolstered with 4,060 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZBH now has a Market Capitalization of 24517660672 and an Enterprise Value of 30272575488. As of this moment, Zimmer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.41, and their Forward P/E ratio for the next fiscal year is 13.74. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.31 while its Price-to-Book (P/B) ratio in mrq is 1.97. Its current Enterprise Value per Revenue stands at 4.094 whereas that against EBITDA is 12.362.
Stock Price History:
Over the past 52 weeks, ZBH has reached a high of $149.25, while it has fallen to a 52-week low of $102.00. The 50-Day Moving Average of the stock is -5.62%, while the 200-Day Moving Average is calculated to be -1.77%.
Shares Statistics:
For the past three months, ZBH has traded an average of 1.44M shares per day and 1170550 over the past ten days. A total of 205.60M shares are outstanding, with a floating share count of 204.81M. Insiders hold about 0.13% of the company’s shares, while institutions hold 91.14% stake in the company. Shares short for ZBH as of 1711584000 were 4732594 with a Short Ratio of 3.28, compared to 1709164800 on 4903107. Therefore, it implies a Short% of Shares Outstanding of 4732594 and a Short% of Float of 2.6099999.
Dividends & Splits
According to the company, the forward annual dividend rate for ZBH is 0.96, from 0.96 in the trailing year. The stock’s 5-year Average Dividend Yield is 0.74.
Earnings Estimates
Currently, Zimmer Biomet Holdings, Inc. analysts are dedicated to thoroughly evaluating and rating the performance of Zimmer Biomet Holdings Inc (ZBH) in the stock market.The consensus estimate for the next quarter is $25.79, with high estimates of $60.41 and low estimates of $0.68.
Analysts are recommending an EPS of between $Consumer Cyclical and $Communication Services for the fiscal current year, implying an average EPS of $Consumer Cyclical.
